Trevena Inc (TRVN)
1.69
-0.06
(-3.43%)
USD |
OTCM |
Nov 04, 16:00
Trevena Total Liabilities (Quarterly): 41.90M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 41.90M |
| March 31, 2024 | 45.79M |
| December 31, 2023 | 48.26M |
| September 30, 2023 | 41.58M |
| June 30, 2023 | 29.08M |
| March 31, 2023 | 28.14M |
| December 31, 2022 | 33.08M |
| September 30, 2022 | 29.16M |
| June 30, 2022 | 28.86M |
| March 31, 2022 | 15.02M |
| December 31, 2021 | 15.50M |
| September 30, 2021 | 13.93M |
| June 30, 2021 | 21.69M |
| March 31, 2021 | 20.43M |
| December 31, 2020 | 23.67M |
| September 30, 2020 | 11.36M |
| June 30, 2020 | 11.00M |
| March 31, 2020 | 10.26M |
| December 31, 2019 | 16.92M |
| September 30, 2019 | 22.19M |
| June 30, 2019 | 22.79M |
| March 31, 2019 | 25.50M |
| December 31, 2018 | 25.25M |
| Date | Value |
|---|---|
| September 30, 2018 | 27.47M |
| June 30, 2018 | 33.63M |
| March 31, 2018 | 32.32M |
| December 31, 2017 | 38.09M |
| September 30, 2017 | 37.43M |
| June 30, 2017 | 36.40M |
| March 31, 2017 | 35.84M |
| December 31, 2016 | 36.07M |
| September 30, 2016 | 29.44M |
| June 30, 2016 | 27.59M |
| March 31, 2016 | 28.28M |
| December 31, 2015 | 32.22M |
| September 30, 2015 | 12.93M |
| June 30, 2015 | 15.31M |
| March 31, 2015 | 16.10M |
| December 31, 2014 | 9.035M |
| September 30, 2014 | 9.697M |
| June 30, 2014 | 5.602M |
| March 31, 2014 | 5.308M |
| December 31, 2013 | 3.401M |
| September 30, 2013 | 3.733M |
| June 30, 2013 | 3.935M |
| December 31, 2012 | 8.127M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.26M
Minimum
Mar 2020
48.26M
Maximum
Dec 2023
25.56M
Average
23.67M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 128.22B |
| United Therapeutics Corp | 1.022B |
| Syndax Pharmaceuticals Inc | 42.61M |
| Arcus Biosciences Inc | 551.00M |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.94M |
| Shareholders Equity (Quarterly) | -18.96M |
| Debt to Equity Ratio | -1.663 |
| Current Ratio | 3.464 |
| Net Debt Paydown Yield | -77.67% |